Evaluating Short-Course Tuberculosis Preventive Treatment for Freshmen with Latent TB Infection
Under School Health Services in China
Led by Affiliated Hospital of Nantong University · Updated on 2026-09-10
3000
Participants Needed
2
Research Sites
156 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are studying high school and college freshmen in Meishan City, Sichuan Province, China, who have strong positive tuberculosis TB skin tests indicating latent TB infection. The study evaluates whether taking a short-course preventive treatment can safely lower the risk of developing active TB over a 3 to 4-year period. This prospective, multi-center research integrates TB screening and preventive care into routine campus health services across 26 schools.
Participants with strong positive skin tests and no active TB can voluntarily choose to start one of two World Health Organization-recommended 3-month preventive treatment regimens daily isoniazid plus rifampicin 3HR or twice-weekly isoniazid plus rifapentine 3H2P2. Treatment is supervised in campus clinics using a combination of in-person and smartphone video directly observed therapy. Those who opt not to take medication receive routine health observation without preventive treatment.
During the study, researchers monitor participants for 3 to 4 years to track who develops active TB and to assess treatment safety, including adverse events like liver toxicity. Participants undergo baseline symptom screening, chest x-rays, and skin testing. Data analysis uses advanced methods to address non-random treatment assignment. The primary outcome is the occurrence of active tuberculosis up to four years after initial screening from the time latent TB infection eligibility is confirmed.
CONDITIONS
Brief Title
Latent Infection Freshmen Tracking for Tuberculosis
Research Team
G
Gang Qin, MD, PhD
Y
Yu Zhang, MBBS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
Meishan Municipal Center for Disease Prevention and Control
Collaborating Sponsor
Who Can Participate
Age: 14Years - 24Years
All Genders
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
Matriculating freshmen aged 14 to 24 years enrolled at one of 26 participating educational institutions
Completed baseline tuberculosis screening including symptom check, digital chest radiography, and tuberculin skin test
Strong positive tuberculin skin test reaction (induration 15 mm or more or severe local reactions) with active TB ruled out at baseline
Control group includes students with tuberculin skin test induration less than 15 mm
You will not qualify if you...
Presence of active tuberculosis at baseline screening
Voluntary receipt of Vaccae vaccination for the target cohort
Your Study Journey
Screening
Duration - Up to 2 weeks
Participants are screened for eligibility through symptom checks, chest x-rays, and tuberculin skin testing upon school entry.
1 baseline visit
Treatment or Observation
Duration - 3 months
Participants choose to start one of two 3-month short-course tuberculosis preventive treatments or receive routine health observation without medication. Treatment is supervised in campus health clinics using in-person and video directly observed therapy.
Regular clinic visits and video monitoring
Long-term Follow-up
Duration - 3 to 4 years
Participants are monitored for 3 to 4 years after baseline to track development of active tuberculosis and assess treatment safety.
Periodic health assessments over follow-up period
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Study of N-acetylcysteine NAC with Standard TB Treatment to Prevent Lung Disease After Tuberculosis in Adults Aged 18 to 65
Evaluating Chat-Based Mobile App Zalo to Improve Follow-Up Compliance After Abnormal AI-Interpreted Chest X-Rays for Lung Disease in Vietnam
Using Artificial Intelligence to Improve Tuberculosis Screening with Chest X-rays in Primary Healthcare Settings in China
Testing a New ESAT6CFP10 Skin Test to Detect Latent Tuberculosis Infection in Adults with Rheumatologic Diseases Before Starting Biologic or Targeted Synthetic Treatments
Evaluating Financial and Social Support to Improve Tuberculosis Treatment Outcomes and Reduce Household Costs in Vietnam
Study of Home-Based HIV Self-Testing and PrEP Start During Tuberculosis Household Contact in Uganda
Evaluating Short-Course Tuberculosis Preventive Treatment for Freshmen with Latent TB Infection
Under School Health Services in China
Evaluating Optimal Treatment Lengths for Radiographic, Bacteriologically Unconfirmed Tuberculosis Found Through Active Case Finding
Study of Patients With Tuberculosis, Non-Tubercular Mycobacteriosis, or Latent Tuberculosis Infection
Analyzing Clinical, Epidemiological, and Diagnostic Aspects from 2012 to 2026
Study on Patient Decisions and Preferences for Preventive Tuberculosis Treatment
Using a Discrete Choice Experiment
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Effectiveness of the primary Bacillus Calmette-Guérin vaccine against the risk of Mycobacterium tuberculosis infection and tuberculosis disease: a meta-analysis of individual participant data.
Adherence to treatment for tuberculosis infection in children using a comprehensive care strategy: a prospective cohort study with a historical control group.
Iader Rodríguez-Márquez, Dione Benjumea-Bedoya, Andrea Victoria Restrepo-Gouzy...
Treatment completion and safety profile of once-weekly 3HP regimen for tuberculosis preventive treatment in children and adolescents: a systematic review.